Clinical Trials Logo

Anterior Resection Syndrome clinical trials

View clinical trials related to Anterior Resection Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT02869984 Not yet recruiting - Clinical trials for Anterior Resection Syndrome

Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome

Start date: August 2016
Phase: Phase 0
Study type: Interventional

Poor functional outcomes has been reported inevitably, and up to 90% of the patients have experienced bowel habit changes after sphincter-saving surgery for rectal cancer. But, currently there has been no specific treatment for ARS and symptom based empirical management is tried Recently, 5-HT3 receptor antagonists can be used for treatment of IBS-D, and has been revealed to be slowing the bowel movement and improving stool consistency and urgency. We performed the clinical trial with using ramosetron (Irribow®) for the treatment of ARS